Withdrawn before it began
Robotic Bronchoscopy With Cone CT and Indocyanine Green to Aid Removal of Lung Lesions in Patients With Stage I Non-small Cell Lung Cancer or Lung Metastases, REPLACING Study
NCT04987281 · M.D. Anderson Cancer Center · Updated 23 Oct 2024
- What is being tested
- Computed Tomography; Indocyanine Green Solution; Therapeutic Bronchoscopy
- For
- Lung Non-Small Cell Carcinoma; Metastatic Malignant Neoplasm in the Lung; Stage I Lung Cancer AJCC v8
- Kind of study
- Tests a treatment or device on volunteers. Phase 2.
- Who can join
- Ages 18 years to 80 years. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 26 Jan 2022, ends 27 Dec 2023. Registered 3 Aug 2021.
- Results
- None posted yet.
In the researchers' words
This phase II trial studies the use of Ion robotic bronchoscope with a mobile computed tomography (CT) scanner to biopsy tumors and inject a fluorescent dye called indocyanine green to mark the tumor during surgery in patients with stage I non-small cell lung cancer or cancer that has spread to the lung (lung metastases). Sometimes small tumors or those that are not on the surface of the lung can be challenging to remove without making larger incisions. Injecting the dye, may help doctors see the tumor more easily, which may allow for smaller incisions and by being able to see the tumor, doctors may be better able to decide where to make the incisions in order to get all of the tumor out.
Sites
- M D Anderson Cancer CenterHouston, Texas, United States